These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. Bufuralol, a new beta-adrenoceptor blocking agent. Fothergill GA; Francis RJ; Hamilton TC; Osbond JM; Parkes MW Experientia; 1975 Nov; 31(11):1322-3. PubMed ID: 1287 [No Abstract] [Full Text] [Related]
2. Bufuralol, a new beta-adrenoceptor blocking agent. Part 1: synthesis and structure-activity studies in a series of benzofuran-2-ethanolamines. Fothergill GA; Osbond JM; Wickens JC Arzneimittelforschung; 1977; 27(5):978-81. PubMed ID: 18158 [TBL] [Abstract][Full Text] [Related]
3. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology. Hamilton TC; Parkes MW Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114 [TBL] [Abstract][Full Text] [Related]
4. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl. Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595 [TBL] [Abstract][Full Text] [Related]
5. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man. Hicks DC; Phillips EM Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922 [No Abstract] [Full Text] [Related]
6. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol. Magometschnigg D; Bonelli J; Kaik G Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815 [TBL] [Abstract][Full Text] [Related]
7. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)]. Rostan A Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523 [No Abstract] [Full Text] [Related]
8. Beta-adrenoceptor activity of the stereoisomers of the bufuralol alcohol and ketone metabolites. Machin PJ; Hurst DN; Osbond JM J Med Chem; 1985 Nov; 28(11):1648-51. PubMed ID: 2866246 [TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols. Large MS; Smith LH J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol. Magometschnigg D; Bonelli J; Kaik G; Rameis H Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899 [TBL] [Abstract][Full Text] [Related]
14. Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues. Hwang SK; Juhasz A; Yoon SH; Bodor N J Med Chem; 2000 Apr; 43(8):1525-32. PubMed ID: 10780909 [TBL] [Abstract][Full Text] [Related]
15. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog. Blaber LC; Burden DT; Eigenmann R; Gerold M J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality]. Balant L; Gorgia A; Tschopp JM; Revillard C; Fabre J Schweiz Med Wochenschr; 1976 Oct; 106(41):1403-7. PubMed ID: 12563 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological properties of nebivolol, a new antihypertensive compound. Van Lommen G; De Bruyn M; Schroven M J Pharm Belg; 1990; 45(6):355-60. PubMed ID: 1982295 [TBL] [Abstract][Full Text] [Related]